What is bpmx stock

21 Jan 2020 BioPharmX Corporation [BPMX] has 15.38M shares outstanding, amounting to a total market cap of $7.23M. Its stock price has been found in the  27 Dec 2019 BioPharmX Corporation [BPMX] has 15.13M shares outstanding, amounting to a total market cap of $5.43M. Its stock price has been found in the  25 Jun 2019 BPMX Stock Is Up On Clinical Data. In a press release issued in the pre-market this morning, BioPharmX announced positive results from a 

Real-time trade and investing ideas on BioPharmX BPMX from the largest community of traders and investors. Find the latest BioPharmX Corporation (BPMX) stock quote, history, news and other vital information to help you with your stock trading and investing. BPMX | Complete BioPharmX Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. BioPharmX Corporation Common Stock (BPMX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Our stock is listed on the NYSE American under the ticker symbol BPMX. View our latest investor presentation. About · Company · Management Team · Board of  

Company Name: BioPharmX Corp., Stock Symbol: BPMX, Industry: Medical - Drugs, Total Posts: 2994, Last Post: 3/10/2020 2:23:01 PM.

Restricted stock typically is that issued to company insiders with limits on when it may be traded. Dividend Yield A company's dividend expressed as a percentage of its current stock price. BioPharmX Corporation Common Stock (BPMX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. BPMX stock was sold by a variety of institutional investors in the last quarter, including Vivo Capital LLC and Vanguard Group Inc.. Company insiders that have sold Biopharmx company stock in the last year include Anja B Krammer, Stephen Morlock and Vivo Capital Viii, Llc. View Insider Buying and Selling for Biopharmx. But when things look terrible is often the best time to buy a stock. That said, BPMX is only for investors who love to speculate. If the company can get a fresh injection of capital from someone, that should help the share price immensely, but that’s a huge “if.” Market Data by Xignite and BATS BZX Real-Time Price. Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal.

Stock Performance NYSEMKT:BPMX Stock Symbol BPMX Stock Exchange NYSEAMERICAN - NYSE American IPO Date Jul 1, 2015 Valuation at IPO $68M  

27 Dec 2019 BioPharmX Corporation [BPMX] has 15.13M shares outstanding, amounting to a total market cap of $5.43M. Its stock price has been found in the  25 Jun 2019 BPMX Stock Is Up On Clinical Data. In a press release issued in the pre-market this morning, BioPharmX announced positive results from a  Ticker: BPMX. HEAD-0.092298030853271. BioPharmX Corp is registered with the U.S. Security and Exchange Commission and incorporated in the state of  Stock Performance NYSEMKT:BPMX Stock Symbol BPMX Stock Exchange NYSEAMERICAN - NYSE American IPO Date Jul 1, 2015 Valuation at IPO $68M   BioPharmX shares stayed stable 0.00% to $0.36 today. On Dec/11 BPMX rocketed an amazing 12.82%. On December 10th BPMX plummed a hair-raising  

25 Jun 2019 BPMX Stock Is Up On Clinical Data. In a press release issued in the pre-market this morning, BioPharmX announced positive results from a 

Stock Price Forecast for BPMX: BioPharmX Corporation holds several negative signals and is within a very wide and falling trend, so we believe it will still  Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Biopharmx Corp have a median target of 1.00, with a high estimate of 1.00 and a low  27 Jun 2019 That leaves $7.4 million worth of BPMX stock to sell, still an enormous amount compared to its shares outstanding. We will have a better idea in a  Stock analysis for BioPharmX Corp (BPMX:NYSEAmerican) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Biopharmx Corp files for offering of up to $40.3 million of shares of common stock - SEC filing Source text: [http://bit.ly/2l2DwCb] Further company coverage:. Get today's BioPharmX Corp stock price and latest BPMX news as well as BioPharmX real-time stock quotes, technical analysis, full financials and more.

Based on our forecasts, a long-term increase is expected, the "BPMX" stock price prognosis for 2024-10-09 is 1.435 USD. With a 5-year investment, the revenue is expected to be around +324.59%. Your current $100 investment may be up to $424.59 in 2024.

Find the latest BioPharmX Corporation (BPMX) stock quote, history, news and other vital information to help you with your stock trading and investing. BPMX | Complete BioPharmX Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. BioPharmX Corporation Common Stock (BPMX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Our stock is listed on the NYSE American under the ticker symbol BPMX. View our latest investor presentation. About · Company · Management Team · Board of   Researching Biopharmx (NYSEAMERICAN:BPMX) stock? View BPMX's stock price, price target, earnings, forecast, insider trades, and news at MarketBeat. Stock Price Forecast for BPMX: BioPharmX Corporation holds several negative signals and is within a very wide and falling trend, so we believe it will still 

Stock Performance NYSEMKT:BPMX Stock Symbol BPMX Stock Exchange NYSEAMERICAN - NYSE American IPO Date Jul 1, 2015 Valuation at IPO $68M   BioPharmX shares stayed stable 0.00% to $0.36 today. On Dec/11 BPMX rocketed an amazing 12.82%. On December 10th BPMX plummed a hair-raising   BPMX | Complete BioPharmX Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. SAN JOSE, Calif., April 15, 2019 /PRNewswire/ -- BioPharmX Corporation (NYSE American: BPMX) (the "Company"), a specialty pharmaceutical company focused on developing innovative medical dermatology products, today announced that its Board of Directors has approved a reverse stock split of its common stock at a ratio of 1-for-25. Restricted stock typically is that issued to company insiders with limits on when it may be traded. Dividend Yield A company's dividend expressed as a percentage of its current stock price.